Epigenetic Landscape of Parkinson's Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities

Navneet Ammal Kaidery, Shaista Tarannum, Bobby Thomas

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

Parkinson's disease (PD) is a complex multifactorial disorder marked by extensive system-wide pathology, including a substantial loss of nigrostriatal dopaminergic neurons. The etiology of PD remains elusive, but there is considerable evidence that, in addition to well-defined genetic mechanisms environmental factors play a crucial role in disease pathogenesis. How the environment might influence the genetic factors and contribute to disease development and progression remains unclear. In recent years, epigenetic mechanisms such as DNA methylation, chromatin remodeling and alterations in gene expression via non-coding RNAs have begun to be revealed as potential factors in PD pathogenesis. Epigenetic modulation exists throughout life, beginning in prenatal stages, is dependent on the lifestyle, environmental exposure and genetic makeup of an individual and may serve as a missing link between PD risk factors and development of the disease. This chapter sheds light on the emerging role of epigenetics in disease pathogenesis and on prospective interventional strategies for the therapeutic modulation of PD.

Original languageEnglish (US)
Pages (from-to)698-708
Number of pages11
JournalNeurotherapeutics
Volume10
Issue number4
DOIs
StatePublished - Jan 1 2013

Fingerprint

Epigenomics
Parkinson Disease
Beginning of Human Life
Therapeutics
Untranslated RNA
Chromatin Assembly and Disassembly
Dopaminergic Neurons
Environmental Exposure
DNA Methylation
Disease Progression
Life Style
Pathology
Gene Expression

Keywords

  • DNA methylation
  • Epigenetics
  • Histones
  • MicroRNA
  • Parkinson's disease

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Epigenetic Landscape of Parkinson's Disease : Emerging Role in Disease Mechanisms and Therapeutic Modalities. / Ammal Kaidery, Navneet; Tarannum, Shaista; Thomas, Bobby.

In: Neurotherapeutics, Vol. 10, No. 4, 01.01.2013, p. 698-708.

Research output: Contribution to journalReview article

Ammal Kaidery, Navneet ; Tarannum, Shaista ; Thomas, Bobby. / Epigenetic Landscape of Parkinson's Disease : Emerging Role in Disease Mechanisms and Therapeutic Modalities. In: Neurotherapeutics. 2013 ; Vol. 10, No. 4. pp. 698-708.
@article{29dba21580b34af8b0655e922c8f9fc4,
title = "Epigenetic Landscape of Parkinson's Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities",
abstract = "Parkinson's disease (PD) is a complex multifactorial disorder marked by extensive system-wide pathology, including a substantial loss of nigrostriatal dopaminergic neurons. The etiology of PD remains elusive, but there is considerable evidence that, in addition to well-defined genetic mechanisms environmental factors play a crucial role in disease pathogenesis. How the environment might influence the genetic factors and contribute to disease development and progression remains unclear. In recent years, epigenetic mechanisms such as DNA methylation, chromatin remodeling and alterations in gene expression via non-coding RNAs have begun to be revealed as potential factors in PD pathogenesis. Epigenetic modulation exists throughout life, beginning in prenatal stages, is dependent on the lifestyle, environmental exposure and genetic makeup of an individual and may serve as a missing link between PD risk factors and development of the disease. This chapter sheds light on the emerging role of epigenetics in disease pathogenesis and on prospective interventional strategies for the therapeutic modulation of PD.",
keywords = "DNA methylation, Epigenetics, Histones, MicroRNA, Parkinson's disease",
author = "{Ammal Kaidery}, Navneet and Shaista Tarannum and Bobby Thomas",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/s13311-013-0211-8",
language = "English (US)",
volume = "10",
pages = "698--708",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Epigenetic Landscape of Parkinson's Disease

T2 - Emerging Role in Disease Mechanisms and Therapeutic Modalities

AU - Ammal Kaidery, Navneet

AU - Tarannum, Shaista

AU - Thomas, Bobby

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Parkinson's disease (PD) is a complex multifactorial disorder marked by extensive system-wide pathology, including a substantial loss of nigrostriatal dopaminergic neurons. The etiology of PD remains elusive, but there is considerable evidence that, in addition to well-defined genetic mechanisms environmental factors play a crucial role in disease pathogenesis. How the environment might influence the genetic factors and contribute to disease development and progression remains unclear. In recent years, epigenetic mechanisms such as DNA methylation, chromatin remodeling and alterations in gene expression via non-coding RNAs have begun to be revealed as potential factors in PD pathogenesis. Epigenetic modulation exists throughout life, beginning in prenatal stages, is dependent on the lifestyle, environmental exposure and genetic makeup of an individual and may serve as a missing link between PD risk factors and development of the disease. This chapter sheds light on the emerging role of epigenetics in disease pathogenesis and on prospective interventional strategies for the therapeutic modulation of PD.

AB - Parkinson's disease (PD) is a complex multifactorial disorder marked by extensive system-wide pathology, including a substantial loss of nigrostriatal dopaminergic neurons. The etiology of PD remains elusive, but there is considerable evidence that, in addition to well-defined genetic mechanisms environmental factors play a crucial role in disease pathogenesis. How the environment might influence the genetic factors and contribute to disease development and progression remains unclear. In recent years, epigenetic mechanisms such as DNA methylation, chromatin remodeling and alterations in gene expression via non-coding RNAs have begun to be revealed as potential factors in PD pathogenesis. Epigenetic modulation exists throughout life, beginning in prenatal stages, is dependent on the lifestyle, environmental exposure and genetic makeup of an individual and may serve as a missing link between PD risk factors and development of the disease. This chapter sheds light on the emerging role of epigenetics in disease pathogenesis and on prospective interventional strategies for the therapeutic modulation of PD.

KW - DNA methylation

KW - Epigenetics

KW - Histones

KW - MicroRNA

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84886315002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886315002&partnerID=8YFLogxK

U2 - 10.1007/s13311-013-0211-8

DO - 10.1007/s13311-013-0211-8

M3 - Review article

C2 - 24030213

AN - SCOPUS:84886315002

VL - 10

SP - 698

EP - 708

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 4

ER -